Innopharma offers comprehensive services across every stage of early drug discovery, from target identification to preliminary safety and toxicity evaluation. With state-of-the-art screening platforms, advanced assay development, and more than 25 years of expertise, we deliver tailored, high-quality solutions to research centers, biotech, and pharmaceutical companies across all therapeutic areas. Our team of experienced scientists works closely with you to design custom approaches, generate reliable data, and provide the support you need to move your discovery forward with confidence.
We help you identify and validate the most promising biological targets using cutting-edge tools and expert insight—laying the foundation for successful drug discovery.
Our team designs and optimizes robust, reproducible assays tailored to your targets, ensuring reliable results for screening and profiling.
Accelerate your discovery with our high-throughput screening platforms and our chemical library of well-
annotated compounds to identify active molecules with therapeutic potential.
We support the transition from hit compounds to lead candidates through in-depth profiling, structure-activity analysis, and early optimization strategies.
Refine your lead compounds for potency, selectivity, and drug-like properties with our ADME-Tox expertise.
From target to candidate, we offer a seamless, end-to-end drug discovery service tailored to your project goals—efficient, collaborative, and science-driven.